tert-butylhydroperoxide has been researched along with Kidney Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dutta, S; Mahalanobish, S; Saha, S; Sil, PC | 1 |
| Chang, Y; Li, Y; Liu, Z; Yu, J; Yu, L | 1 |
2 other study(ies) available for tert-butylhydroperoxide and Kidney Diseases
| Article | Year |
|---|---|
Mangiferin ameliorates collateral neuropathy in tBHP induced apoptotic nephropathy by inflammation mediated kidney to brain crosstalk.
Topics: Animals; Apoptosis; Brain; Humans; Interleukin-6; Kidney; Kidney Diseases; Male; Mice; Oxidative Stress; Phosphatidylinositol 3-Kinases; Reactive Oxygen Species; tert-Butylhydroperoxide; Tumor Necrosis Factor-alpha; Xanthones | 2019 |
Penehyclidine hydrochloride inhibits renal ischemia/reperfusion-induced acute lung injury by activating the Nrf2 pathway.
Topics: Acute Lung Injury; Animals; Apoptosis; Disease Models, Animal; Gene Knockout Techniques; Humans; Kidney; Kidney Diseases; Lung; Macrophages, Alveolar; Male; NF-E2-Related Factor 2; Oxidative Stress; Quassins; Quinuclidines; Rats; Rats, Transgenic; Reactive Oxygen Species; Reperfusion Injury; Signal Transduction; tert-Butylhydroperoxide | 2020 |